Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar® [Phase 4]
Phase 4 clinical trial evaluating how different antirheumatic treatments affect antibody response to vaccination with Prevenar in rheumatoid…
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis [Phase 2]
Phase 2 trial evaluating oral AB1010 in adults with active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Effect of Some Drugs on Rheumatoid Arithritis Activity [Phase 3]
Phase 3 clinical trial update evaluating the effect of some drugs on rheumatoid arthritis activity.
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Statins and ARBs on Rheumatoid Activity [Phase 3]
A Phase 3 clinical trial is investigating the effects of statins and ARBs on rheumatoid arthritis activity and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis. [Phase 4]
A Phase 4 clinical trial assessing the effectiveness of different early rheumatoid arthritis treatment strategies in real-world practice; re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent [Phase 3]
Phase 3 trial evaluating tocilizumab (RoActemra/Actemra) as monotherapy or with non-biologic DMARDs in rheumatoid arthritis patients with in…
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy [Phase 2]
Phase 2 clinical trial update for rheumatoid arthritis patients on methotrexate with inadequate response to TNF inhibitor therapy; results p…
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 trial update assessing long-term safety and efficacy of BI 695501 in rheumatoid arthritis completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions [NA]
Clinical trial update comparing Augment Injectable Bone Graft to autologous bone graft for hindfoot fusions; study completed with results po…
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate [Phase 2]
Phase 2 clinical trial evaluating Pf-06651600 for rheumatoid arthritis with inadequate response to methotrexate has completed with results p…
-
CLINICAL_TRIALS trial_result · 2018-12-03Clinical Trial Update: Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice
Clinical trial update on etanercept focusing on remission in real-life practice for rheumatoid arthritis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-12-03Clinical Trial Update: Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria
A completed clinical trial assessing the safety and efficacy of Etanercept (Enbrel) in patients with moderately active rheumatoid arthritis …
-
CLINICAL_TRIALS trial_result · 2018-11-29Clinical Trial Update: Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab [Phase 4]
Phase 4 trial exploring musculoskeletal ultrasound to predict early dose titration of tocilizumab in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis [Phase 2]
Phase 2 mechanistic study of GSK3196165 plus methotrexate in active rheumatoid arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis. [Phase 2]
Phase 2 trial updating on enalapril maleate for arterial stiffness in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-13Clinical Trial Update: A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis [Phase 3]
Phase 3 clinical trial updates the use of subcutaneous tocilizumab as monotherapy or with non-biologic DMARDs in rheumatoid arthritis; resul…
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate [Phase 2]
Phase 2 study evaluating safety and pharmacokinetics of the P38 inhibitor PH-797804 in rheumatoid arthritis patients on methotrexate.
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy [Phase 3]
Phase 3 study of tocilizumab in RA patients naive to tocilizumab with inadequate response to DMARDs or prior biologic therapy completed; res…
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis [Phase 1]
Phase I trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of multiple IV doses of PF-04236921 in patients with rh…
-
CLINICAL_TRIALS trial_result · 2018-11-01Clinical Trial Update: Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background Methotrexate Therapy [Phase 2]
Phase 2 clinical trial update of oral baricitinib (LY3009104) in Japanese patients with active rheumatoid arthritis on background methotrexa…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action [Phase 4]
A Phase 4 randomized biomarker trial completed in rheumatoid arthritis evaluating therapeutic responses to a specific biologic mode of actio…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial update evaluating injection site pain with a new etanercept formulation in adults with rheumatoid arthritis or psoria…
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: A Study for Japanese Participants With Rheumatoid Arthritis (RA) [Phase 1]
Phase 1 clinical trial update for Japanese participants with rheumatoid arthritis; study completed and results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044 [Phase 3]
Open-label extension study of certolizumab pegol in Chinese patients with rheumatoid arthritis who participated in a Phase 3 trial (RA0044).
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: 6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection [Phase 1, Phase 2]
Open-label phase 1/2 trial update of PRTX-100 in prior rheumatoid arthritis participants with sera collection; study completed.